We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

85 hedge funds and large institutions have $166M invested in Immunomedics Inc in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 16

17% more call options, than puts

Call options by funds: $15.2M | Put options by funds: $12.9M

9% more capital invested

Capital invested by funds: $153M → $166M (+$13.1M)

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

1% less funds holding

Funds holding: 86 → 85 (-1)

Holders
85
Holders Change
-1
Holders Change %
-1.16%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
36
Reduced
16
Closed
14
Calls
$15.2M
Puts
$12.9M
Net Calls
+$2.24M
Net Calls Change
-$940K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$2.45M
2
Millennium Management
Millennium Management
New York
+$1.4M
3
BFA
BlackRock Fund Advisors
California
+$893K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$772K
5
WCM Investment Management
WCM Investment Management
California
+$422K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tekla Capital Management
Massachusetts
-$1.92M
2
HCMT
Highland Capital Management (Texas)
Texas
-$849K
3
CS
Candriam SCA
Luxembourg
-$797K
4
SM
Sabby Management
Florida
-$528K
5
BAMS
Bellevue Asset Management (Switzerland)
Switzerland
-$409K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$56.9M +$772K +188,722 +1%
BFA
2
BlackRock Fund Advisors
California
$15.2M +$893K +218,347 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$13M +$339K +82,990 +3%
BIT
4
BlackRock Institutional Trust
California
$11.9M -$139K -33,918 -1%
DM
5
Deerfield Management
New York
$10.2M -$409 -100 -0%
WCM Investment Management
6
WCM Investment Management
California
$8.09M +$422K +103,219 +5%
State of Wisconsin Investment Board
7
State of Wisconsin Investment Board
Wisconsin
$6.09M – – –
State Street
8
State Street
Massachusetts
$5.35M +$156K +38,251 +3%
Northern Trust
9
Northern Trust
Illinois
$3.93M +$22.9K +5,594 +0.6%
PA
10
Perceptive Advisors
New York
$2.44M +$2.45M +600,000 New
Bank of New York Mellon
11
Bank of New York Mellon
New York
$2.28M +$143K +35,018 +7%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$2.22M +$50.7K +12,411 +2%
TCIM
13
TIAA CREF Investment Management
New York
$1.75M +$136K +33,359 +8%
Millennium Management
14
Millennium Management
New York
$1.4M +$1.4M +343,648 New
BIM
15
BlackRock Investment Management
Delaware
$1.39M +$399K +97,612 +40%
CS
16
Candriam SCA
Luxembourg
$1.34M -$797K -195,000 -37%
BAMS
17
Bellevue Asset Management (Switzerland)
Switzerland
$1.22M -$409K -100,000 -25%
JPTCCM
18
J.P. Turner & Co Capital Management
Georgia
$1.01M +$51.9K +12,700 +5%
SFM
19
Sphera Funds Management
Israel
$995K -$225K -55,000 -18%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$943K -$109K -26,760 -10%
PAM
21
Panagora Asset Management
Massachusetts
$930K +$199K +48,667 +27%
BCM
22
Bridgeway Capital Management
Texas
$905K -$9.81K -2,400 -1%
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$898K -$54K -13,216 -6%
SGAM
24
Smith Group Asset Management
Texas
$857K +$15.9K +3,890 +2%
Charles Schwab
25
Charles Schwab
California
$799K – – –
1
2 3 4

IMMU Hedge Fund Activity: Q2 2015 in Review

85 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2015, worth a combined $166M — up 8.6% from $153M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of IMMU and 13 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 36 added.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.45M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $1.92M sold.

  • 85 institutional investors held Immunomedics Inc (IMMU) as of Q2 2015, down from 86 in Q1 2015.
  • Funds reported $166M of Immunomedics Inc stock for Q2 2015, up 8.6% quarter-over-quarter.
  • 13 funds opened new Immunomedics Inc positions in Q2 2015 and 14 closed out, a net change of -1 holder.
  • The largest Immunomedics Inc buyer in Q2 2015 was Perceptive Advisors, an estimated $2.45M added.
  • The largest Immunomedics Inc seller in Q2 2015 was Tekla Capital Management, an estimated $1.92M sold.

Based on aggregated 13F filings for Q2 2015.